Bayer and Kumquat initiate Phase I study with KRAS G12D inhibitor in patients with KRAS-mutated tumors
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
BIL also holds an option to increase its equity stake by an additional 15%
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
This predictive technology empowers people with diabetes to take preventive action before complications arise
Encouraging early detection and breaking the silence around men’s health
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
CRISPR-based detection enables highly specific molecular recognition
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
Subscribe To Our Newsletter & Stay Updated